Codexis Inc (CDXS)
3.815
+0.32
(+9.31%)
USD |
NASDAQ |
Nov 05, 16:00
3.82
0.00 (0.00%)
After-Hours: 20:00
Codexis Shareholders Equity (Quarterly): 73.40M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 73.40M |
June 30, 2024 | 61.45M |
March 31, 2024 | 79.27M |
December 31, 2023 | 86.62M |
September 30, 2023 | 91.51M |
June 30, 2023 | 124.13M |
March 31, 2023 | 126.02M |
December 31, 2022 | 144.80M |
September 30, 2022 | 154.13M |
June 30, 2022 | 159.46M |
March 31, 2022 | 158.64M |
December 31, 2021 | 164.39M |
September 30, 2021 | 169.06M |
June 30, 2021 | 162.77M |
March 31, 2021 | 163.74M |
December 31, 2020 | 170.10M |
September 30, 2020 | 90.80M |
June 30, 2020 | 94.79M |
March 31, 2020 | 99.07M |
December 31, 2019 | 105.52M |
September 30, 2019 | 102.51M |
June 30, 2019 | 98.68M |
March 31, 2019 | 51.21M |
December 31, 2018 | 56.31M |
September 30, 2018 | 54.77M |
Date | Value |
---|---|
June 30, 2018 | 52.53M |
March 31, 2018 | 15.07M |
December 31, 2017 | 24.55M |
September 30, 2017 | 22.09M |
June 30, 2017 | 30.64M |
March 31, 2017 | 11.68M |
December 31, 2016 | 19.10M |
September 30, 2016 | 22.84M |
June 30, 2016 | 19.68M |
March 31, 2016 | 16.11M |
December 31, 2015 | 22.88M |
September 30, 2015 | 23.31M |
June 30, 2015 | 17.10M |
March 31, 2015 | 21.62M |
December 31, 2014 | 26.31M |
September 30, 2014 | 25.21M |
June 30, 2014 | 29.33M |
March 31, 2014 | 36.57M |
December 31, 2013 | 41.48M |
September 30, 2013 | 50.87M |
June 30, 2013 | 59.47M |
March 31, 2013 | 70.74M |
December 31, 2012 | 78.44M |
September 30, 2012 | 93.00M |
June 30, 2012 | 92.51M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
61.45M
Minimum
Jun 2024
170.10M
Maximum
Dec 2020
123.98M
Average
125.07M
Median
Shareholders Equity (Quarterly) Benchmarks
Rhythm Pharmaceuticals Inc | 179.50M |
Allogene Therapeutics Inc | 515.04M |
Maravai LifeSciences Holdings Inc | 436.93M |
Artiva Biotherapeutics Inc | -174.67M |
CEL-SCI Corp | 8.473M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 148.18M |
Total Liabilities (Quarterly) | 74.78M |
Debt to Equity Ratio | 0.3901 |
Current Ratio | 3.214 |
Net Debt Paydown Yield | -2.28% |